share_log

科濟藥業-B：第八次經修訂及重訂組織章程大綱及細則

CARSGEN-B: EIGHTH AMENDED AND RESTATEDMEMORANDUM AND ARTICLES OF ASSOCIATION

Hong Kong Stock Exchange ·  May 21 09:50
Summary by Moomoo AI
科濟藥業控股有限公司（CARsgen Therapeutics Holdings Limited）於2024年5月21日通過特別決議案，完成了對公司組織章程大綱及細則的第八次修訂及重訂。該修訂涵蓋了公司名稱、註冊辦事處地址、公司成立目的、股東責任、公司股本結構、公司註冊地變更權利等多個方面。此次修訂旨在更新公司的組織架構和運營規則，以符合當前的業務需求和法律法規的要求。修訂後的組織章程大綱及細則將對公司的治理結構和未來運營產生重要影響。
科濟藥業控股有限公司（CARsgen Therapeutics Holdings Limited）於2024年5月21日通過特別決議案，完成了對公司組織章程大綱及細則的第八次修訂及重訂。該修訂涵蓋了公司名稱、註冊辦事處地址、公司成立目的、股東責任、公司股本結構、公司註冊地變更權利等多個方面。此次修訂旨在更新公司的組織架構和運營規則，以符合當前的業務需求和法律法規的要求。修訂後的組織章程大綱及細則將對公司的治理結構和未來運營產生重要影響。
CarsGen Therapeutics Holdings Limited passed a special resolution on 21 May 2024, completing the eighth revision and revision of the Company's Articles of Association and Conditions. The amendment covers a number of aspects such as the name of the company, the address of the registered office, the purpose of incorporation, the shareholders' liability, the company's share capital structure, the right to change the place of incorporation of the company. This revision aims to update the company's organizational structure and operating rules to meet current business needs and legal and regulatory requirements. THE REVISED ARTICLES OF ASSOCIATION AND RULES WILL HAVE A SIGNIFICANT IMPACT ON THE COMPANY'S GOVERNANCE STRUCTURE AND FUTURE OPERATIONS.
CarsGen Therapeutics Holdings Limited passed a special resolution on 21 May 2024, completing the eighth revision and revision of the Company's Articles of Association and Conditions. The amendment covers a number of aspects such as the name of the company, the address of the registered office, the purpose of incorporation, the shareholders' liability, the company's share capital structure, the right to change the place of incorporation of the company. This revision aims to update the company's organizational structure and operating rules to meet current business needs and legal and regulatory requirements. THE REVISED ARTICLES OF ASSOCIATION AND RULES WILL HAVE A SIGNIFICANT IMPACT ON THE COMPANY'S GOVERNANCE STRUCTURE AND FUTURE OPERATIONS.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more